AT266126B - Process for the stabilization of 4-methyl-5- (2'-chloroethyl) -thiazole - Google Patents

Process for the stabilization of 4-methyl-5- (2'-chloroethyl) -thiazole

Info

Publication number
AT266126B
AT266126B AT151867A AT151867A AT266126B AT 266126 B AT266126 B AT 266126B AT 151867 A AT151867 A AT 151867A AT 151867 A AT151867 A AT 151867A AT 266126 B AT266126 B AT 266126B
Authority
AT
Austria
Prior art keywords
chloroethyl
thiazole
stabilization
methyl
Prior art date
Application number
AT151867A
Other languages
German (de)
Inventor
Thore Oskar Vaerner Rydh
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of AT266126B publication Critical patent/AT266126B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT151867A 1966-03-08 1967-02-16 Process for the stabilization of 4-methyl-5- (2'-chloroethyl) -thiazole AT266126B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE303166A SE319577B (en) 1966-03-08 1966-03-08

Publications (1)

Publication Number Publication Date
AT266126B true AT266126B (en) 1968-11-11

Family

ID=20261249

Family Applications (1)

Application Number Title Priority Date Filing Date
AT151867A AT266126B (en) 1966-03-08 1967-02-16 Process for the stabilization of 4-methyl-5- (2'-chloroethyl) -thiazole

Country Status (6)

Country Link
AT (1) AT266126B (en)
BE (1) BE693977A (en)
DE (1) DE1617286B1 (en)
GB (1) GB1147731A (en)
NL (1) NL156921B (en)
SE (1) SE319577B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247702A (en) * 1978-04-25 1981-01-27 Pharmaceutical Licences Company Ltd. Method of stabilizing 4-methyl-5-(2'chloroethyl)-thiazol

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247702A (en) * 1978-04-25 1981-01-27 Pharmaceutical Licences Company Ltd. Method of stabilizing 4-methyl-5-(2'chloroethyl)-thiazol
DK155978B (en) * 1978-04-25 1989-06-12 Astra Ab METHOD FOR STABILIZING 4-METHYL-5- (2'-CHLORETHYL) THIAZOL

Also Published As

Publication number Publication date
DE1617286B1 (en) 1971-05-27
SE319577B (en) 1970-01-19
GB1147731A (en) 1969-04-02
BE693977A (en) 1967-08-14
NL156921B (en) 1978-06-15
NL6702002A (en) 1967-09-11

Similar Documents

Publication Publication Date Title
CH515922A (en) Process for the preparation of thiazole derivatives
AT303955B (en) Process for the preparation of cephalosporin derivatives
CH544119A (en) Process for the preparation of optically active thiadiazoles
CH478133A (en) Process for the preparation of isothiazole derivatives
CH469739A (en) Process for the preparation of cephalosporin derivatives
CH485762A (en) Process for the preparation of thiazolidines
CH480308A (en) Process for the preparation of thiosemicarbazide compounds
CH529162A (en) Process for the preparation of thiazolines 3
CH488721A (en) Process for the preparation of isothiazoles
AT265507B (en) Process for the manufacture of dentures
CH495975A (en) Process for the preparation of aminoalkyl-substituted phthalans
CH448119A (en) Process for the preparation of triarylalkane derivatives
CH417604A (en) Process for the preparation of benzamidobenzanilide derivatives
AT266126B (en) Process for the stabilization of 4-methyl-5- (2'-chloroethyl) -thiazole
CH478134A (en) Process for the preparation of thiadiazoles
CH478832A (en) Process for the preparation of thiadiazoles
CH472429A (en) Process for the preparation of 5-nitro-furfurylidene- (2) -imino derivatives
CH494731A (en) Process for the preparation of derivatives of dibenzocyclo-heptene
CH482711A (en) Process for the preparation of isothiazoles
CH468398A (en) Process for the preparation of 2- (a-perbromoalkyl) -2-oxazolines
CH470366A (en) Process for the preparation of sulfamide derivatives
CH488720A (en) Process for the preparation of isothiazole derivatives
CH445473A (en) Process for the preparation of iminocycloheptatriene derivatives
CH491135A (en) Process for the preparation of thiazole derivatives
CH487861A (en) Process for the preparation of N-trifluoromethylated sulfenamides